Search results

After reading this case study, the students will be able to analyze an external environment using the PESTLE framework for identifying key factors and assessing their impact on strategic decision-making, evaluate the importance of the company, competitors and customers in strategic decision-making and how the 3Cs model provides useful insights in a competitive environment and get useful insights from PESTLE and the Ansoff matrix for making well-informed strategic growth decisions.

The Indus Bakers, led by Suresh Kumar, Ajeet Kumar and Kareem Ahmed, faced stagnant sales in Sukkur’s bustling bakery industry. Expanding from Larkana, the bakery grapples with fierce competition from newcomers and home-based bakers. Managers discuss concerns over market shifts and cost constraints, placing Suresh in a pivotal decision-making role. He must decide whether to introduce specialized dietary offerings, set up kiosks at transport hubs, explore local tea culture or target corporate clients. Each path poses challenges and opportunities. As the Indus Bakers stand at this critical juncture, Kumar’s choices will define its role in Sukkur’s evolving bakery landscape, blending tradition with adaptability in a dynamic market.

This case study is suitable for teaching the graduates of management sciences, Bachelor of Business Administration and Master of Business Administration programs, particularly in the courses of corporate strategy, marketing management and entrepreneurship. It offers valuable insights to students and helps in strategic decision-making within the business landscape, emphasizing the consideration of both macro and micro environmental factors. This case study equips learners to digest how companies navigate competitive markets and adapt their strategies in response to changing market dynamics. Through exploring the challenges faced by the Indus Bakers and their strategic responses, students can glean practical lessons in corporate strategy, environmental analysis, competitive strategy, market analysis and business resilience. This approach prepares students to tackle real-world business scenarios, fostering critical thinking and strategic acumen essential for future business leaders.

Teaching notes are available for educators only.

CSS 11: Strategy.

Case information was mainly acquired through interviews with Richard Gammans, chief operating officer. Dr Gammans was a visiting professor at Fayetteville State University for a year, and two of the case authors developed personal friendships with Richard. Interviews were conducted over a two-year period as the accelerator got started. In addition, one author conducted a team-building session with the management team and one of the bio-startup researchers. An interview was also conducted with Clayton Duncan, chief executive officer, to gain his agreement with developing the case.

The Accele website included a write-up on each of the pharmaceutical startup companies. The write-up included a company summary, description of the science (disease and cure), the size of the market, results from testing, regulatory considerations and intellectual property. A literature review was conducted as the basis for the information on the pharmaceutical industry.

This case is about a biopharmaceutical accelerator founded in 2011 by two senior executives with experience in both large pharmaceutical companies and running biotech startup companies. The founders were successful in raising capital to start their first venture capital fund which they used to invest in four biotech startups. All four startups were working in very different disease areas. For example, one developed a drug to help with hearing loss that the department of defense was funding. Another of the startups discovered drug candidates that attack antibiotic-resistant bacteria. Biopharmaceutical accelerators were relatively new. They differed from business incubators because they invest in the startups and provide operational support, but the degree of support provided varies across accelerators. The Accele BioPharma accelerator operated in virtual, network type of organization, and Accele BioPharma provided primary strategic and operational management for the startups. The challenge in this case is to identify how the leaders managed the virtual network, and what additional resources were needed so that the management team could expand their ability to assist startups to get drugs approved by the food and drug administration.

This case is suitable recommended for undergraduate/graduate strategy, undergraduate/graduate organizational behavior, entrepreneurship and health-care management courses.